Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
MiniMed Group, Inc.
Market Cap
$560.00M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$562.76M
Return on Assets (ROA)
-20.89%
TTM Avg
7.49%
3Y Avg
-5.84%
5Y Avg
-12.60%
Market Cap
$564.85M
Return on Assets (ROA)
20.70%
TTM Avg
2.32%
3Y Avg
-24.93%
5Y Avg
-30.88%
Market Cap
$571.50M
Return on Assets (ROA)
-59.22%
TTM Avg
-47.88%
3Y Avg
-51.20%
5Y Avg
-67.88%
Market Cap
$542.36M
Return on Assets (ROA)
-37.16%
TTM Avg
-32.95%
3Y Avg
-32.95%
5Y Avg
-32.95%
Market Cap
$540.28M
Return on Assets (ROA)
-124.45%
TTM Avg
-92.75%
3Y Avg
-98.77%
5Y Avg
-98.11%
Market Cap
$538.40M
Return on Assets (ROA)
-42.15%
TTM Avg
-50.20%
3Y Avg
-44.84%
5Y Avg
-47.93%
Market Cap
$537.99M
Return on Assets (ROA)
-30.29%
TTM Avg
-86.87%
3Y Avg
-85.61%
5Y Avg
-77.02%
Market Cap
$536.81M
Return on Assets (ROA)
0.39%
TTM Avg
-16.14%
3Y Avg
-90.03%
5Y Avg
-84.55%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $562.76M | -20.89% | 7.49% | -5.84% | -12.60% |
| CorMedix Inc. (CRMD)vs › | $564.85M | 20.70% | 2.32% | -24.93% | -30.88% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $571.50M | -59.22% | -47.88% | -51.20% | -67.88% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $542.36M | -37.16% | -32.95% | -32.95% | -32.95% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $540.28M | -124.45% | -92.75% | -98.77% | -98.11% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $538.40M | -42.15% | -50.20% | -44.84% | -47.93% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $537.99M | -30.29% | -86.87% | -85.61% | -77.02% |
| Delcath Systems, Inc. (DCTH)vs › | $536.81M | 0.39% | -16.14% | -90.03% | -84.55% |
| ProKidney Corp. (PROK)vs › | $536.32M | -34.82% | -17.21% | -15.93% | -60.12% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
